Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prostatic Neoplasms × Embolization, Therapeutic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Hepatocellular 6 Neoplasm Metastasis 4 Liver Neoplasms 4 Leiomyoma 3 Uveal Melanoma 1 Spinal Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pelvic Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Chylous Ascites 1 Blood Loss, Surgical 1 Abdominal Neoplasms 1

Interventions

Docetaxel 145 Prednisone 110 Leuprolide 81 Radiotherapy 70 enzalutamide 69 bicalutamide 68 Goserelin 66 Abiraterone Acetate 66 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 48 Zoledronic Acid 37 Magnetic Resonance Spectroscopy 34 Estramustine 29 gallium 68 PSMA-11 27 abiraterone 27 apalutamide 26 Flutamide 26 radium Ra 223 dichloride 24 Radiosurgery 22 Gonadotropin-Releasing Hormone 21 cabazitaxel 20 Dutasteride 20 Androgen Antagonists 20 sipuleucel-T 19 Surveys and Questionnaires 18 Radiation 18 Exercise 17 Brachytherapy 17 luprolide acetate gel depot 16 Triptorelin Pamoate 16 Prednisolone 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03407963 2025-12-04

CAPEMBOL

Centre Hospitalier Universitaire de Nīmes

Phase NA Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡